Loading…
Diebold Nixdorf, Incorporated is projected to rise to $90.89 by 2027, a +28% move from its current price of $71.26. DBD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $69.69 | $71.28 | $72.92 | +0.03% |
| Aug 2 | $69.06 | $71.31 | $73.63 | +0.07% |
| Aug 3 | $68.58 | $71.33 | $74.19 | +0.10% |
| Aug 4 | $68.19 | $71.36 | $74.67 | +0.13% |
| Aug 5 | $67.85 | $71.38 | $75.09 | +0.17% |
| Aug 6 | $67.54 | $71.40 | $75.48 | +0.20% |
| Aug 7 | $67.27 | $71.43 | $75.84 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $67.27 | $71.43 | $75.84 | +0.23% |
| Week 2 | $65.77 | $71.59 | $77.94 | +0.47% |
| Week 3 | $64.68 | $71.76 | $79.62 | +0.70% |
| Week 4 | $63.79 | $71.93 | $81.10 | +0.94% |
| Week 5 | $63.04 | $72.10 | $82.45 | +1.18% |
| Week 6 | $62.39 | $72.27 | $83.71 | +1.41% |
| Week 7 | $61.80 | $72.44 | $84.90 | +1.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Diebold Nixdorf, Incorporated is a technology company that automates, digitizes, and transforms the way people bank and shop worldwide. It operates through two segments, Banking and Retail, and offers automated teller machines, cash recyclers, dispensers, teller automation tools, and kiosk technologies.
The Banking segment manufactures and sells branch automation solutions, including DN Series recyclers, ATMs, cash recycling technology, and the DN Teller Cash Recycler and Dual Tower Recycler, as well as provides multi-vendor service capabilities and DN Vynamic software for enhanced connectivity and analytics. The Retail segment offers modular and integrated electronic point-of-sale (EPOS) systems, self-checkout solutions like DN Series EASY ONE and EASY MAX Kiosk, BEETLE POS systems, and a broad range of peripherals, including printers, scales, and mobile scanners. It also provides the DN Vynamic Retail Platform, which includes industry-specific solutions for fuel, convenience, specialty, fashion, and grocery; and platforms for digital receipts, rewards, data analysis, and compliance, as well as offers maintenance, support, global integration, remote device monitoring, and advisory services utilizing AI for predictive diagnostics and operational efficiencies.
The company provides integrated core operations supporting security and efficient cash management, with offerings including installation, maintenance, managed services, automation, and data intelligence via the Allconnect data engine.
The company was formerly known as Diebold, Incorporated and changed its name to Diebold Nixdorf, Incorporated in December 2016. Diebold Nixdorf, Incorporated was founded in 1859 and is headquartered in North Canton, Ohio.
Diebold Nixdorf, Incorporated (DBD) is a technology company focused on automating and digitizing banking and retail workflows through its Banking and Retail segments.
The stock is currently trading at $75.17 and carries a market cap of $2.6B, ranking 1847 by market capitalization.
A major floor 18.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 27.4% above — a clean break opens room to run.
A major ceiling 36.5% above — clearing it would confirm fresh momentum.
Key DBD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DBD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $83.45 | Sell | $80.16 | Sell |
| MA 10 | $85.05 | Sell | $83.04 | Sell |
| MA 20 | $84.79 | Sell | $83.97 | Sell |
| MA 50 | $82.38 | Sell | $82.78 | Sell |
| MA 100 | $80.31 | Sell | $80.10 | Sell |
| MA 200 | $73.96 | Sell | $74.45 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 27.48 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -317.72 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -1.42 | Sell |
| ROC (12) | -16.72 | Sell |
| Bollinger %B (20,2) | -0.26 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | -0.64 | Sell |
| Ultimate (7,14,28) | 21.58 | Buy |
| Momentum (10) | -13.91 | Sell |
| Aroon Osc (25) | -8.00 | Sell |
| Hull MA (9) | 79.50 | Sell |
| ADX (14) | 25.37 | Sell |
| ATR (14) | 2.15 | Info |
Key near-term technicals show a bullish tilt with a defined 30-day boundary. The stock trades within a 30-day range of $65.75 to $85.94, reflecting interim volatility but upside potential as momentum remains constructive.
The RSI(14) sits at 30, with a 50-day simple moving average of $82.34 and a 200-day simple moving average of $73.88, suggesting the price is docked near short-term resistance and near-term support sits at $75.17 while the main resistance is at $90.75. A close look at the price action around these levels can help cue the next directional move.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $63.96 | $71.26 | $95.75 | 0% | Neutral | |
| $73.60 | $90.89 | $117.96 | +28% | Bullish | |
| $95.90 | $121.20 | $162.39 | +70% | Bullish | |
| $109.27 | $140.73 | $193.34 | +97% | Bullish | |
| $119.40 | $156.35 | $219.37 | +119% | Bullish | |
| $130.43 | $173.39 | $247.80 | +143% | Bullish | |
| $132.74 | $178.94 | $260.00 | +151% | Bullish | |
| $159.86 | $218.33 | $322.02 | +206% | Bullish | |
| $195.44 | $270.23 | $404.11 | +279% | Bullish | |
| $201.91 | $282.48 | $427.91 | +296% | Bullish | |
| $313.29 | $462.13 | $738.96 | +549% | Bullish | |
| $548.14 | $884.01 | $1,530.48 | +11.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $63.96 | $71.26 | $83.05 | +0.00% |
| August 2026 | $61.08 | $71.43 | $85.30 | +0.24% |
| September 2026 | $62.39 | $73.46 | $88.71 | +2.85% |
| October 2026 | $65.16 | $77.15 | $93.99 | +5.02% |
| November 2026 | $65.58 | $78.01 | $95.72 | +1.11% |
| December 2026 | $64.91 | $77.53 | $95.75 | -0.62% |
Click any year to see its month-by-month DBD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DBD is projected to trade between $63.96 and $95.75, averaging $71.26 — a potential gain of 0% from today's $71.26. A consolidation phase looks the most probable path here.
Diebold Nixdorf, Incorporated's 2027 outlook centres on $90.89, within a $73.60 to $117.96 range. That is up +28% on the projected 2026 average. That marks a +28% change versus current levels. Momentum favours further upside here.
By 2028, DBD could reach as high as $162.39, with a base case around $121.20 and support toward $95.90 — roughly +70% from $71.26. Buyers look set to stay in control over this stretch.
Expect DBD to range from $109.27 to $193.34 through 2029. The $140.73 average target implies a +97% move from current prices. That is up +16% on the projected 2028 average. Momentum favours further upside here.
The DBD price prediction for 2030 points to an average of $156.35 (low $119.40, high $219.37) — a potential gain of +119% on today's $71.26. Buyers look set to stay in control over this stretch.
In 2031, DBD is projected to trade between $130.43 and $247.80, averaging $173.39 — a potential gain of +143% from today's $71.26. That is up +11% on the projected 2030 average. Momentum favours further upside here.
Diebold Nixdorf, Incorporated's 2032 outlook centres on $178.94, within a $132.74 to $260.00 range. That is up +3% on the projected 2031 average. That marks a +151% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DBD could reach as high as $322.02, with a base case around $218.33 and support toward $159.86 — roughly +206% from $71.26. Momentum favours further upside here.
Expect DBD to range from $195.44 to $404.11 through 2034. The $270.23 average target implies a +279% move from current prices. That is up +24% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DBD price prediction for 2035 points to an average of $282.48 (low $201.91, high $427.91) — a potential gain of +296% on today's $71.26. Momentum favours further upside here.
In 2040, DBD is projected to trade between $313.29 and $738.96, averaging $462.13 — a potential gain of +549% from today's $71.26. That is up +64% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Diebold Nixdorf, Incorporated's 2050 outlook centres on $884.01, within a $548.14 to $1,530.48 range. That is up +91% on the projected 2040 average. That marks a +11.4x change versus current levels. Momentum favours further upside here.
Investing $1,000 in DBD today (≈ 14.033118 DBD) could be worth
$12,405.42
+$11,405.42 (+1141%) by 2050 · US Dollar
Based on the average projected DBD price of $884.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DBDwould be worth at today's price.
$1,000 invested in DBD on Jul 30, 2025 (≈ 17.834849 DBD) would be worth
$1,270.91
+$270.91 (+27.1%) today · 1.27× · US Dollar
Based on a DBD entry price of $56.07 vs. today's $71.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $86.98 | $819.27 | -18.1% |
| 1 month ago | $85.02 | $838.16 | -16.2% |
| 3 months ago | $77.86 | $915.23 | -8.5% |
| 6 months ago | $69.01 | $1,032.6 | +3.3% |
| 1 year ago | $56.07 | $1,270.91 | +27.1% |
| All time (3.0y) ago | $20.57 | $3,464.27 | +246.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DBD forecast.
Our base-case forecast reaches $140.00 around 2029.
Implied market cap at $140.00: $4.75B
The multi-year forecast depicts a strong, upward trajectory from 2026 through 2050, underscoring meaningful upside potential despite inherent uncertainty. By 2030, the forecast shows an average price of $173.50 with an ROI of 130.8% and bullish sentiment. The path continues to 2040 with an average of $545.80 and an ROI of 626.1%, and by 2050 the average is projected at $1,066.30 with an ROI of 1318.5% and continued bullish sentiment.
These figures illustrate a long-term growth scenario with the potential for substantial gains, but they are estimates and not guarantees. Economic, competitive, and market conditions could influence actual outcomes beyond the projected paths.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $173.50 with a min of $134.42 and a max of $239.04, and an ROI of 130.8% with bullish sentiment.
The forward view indicates a bullish trajectory across years, with averages rising from $75.17 in 2026 to $173.50 in 2030 and up to $1,066.30 by 2050, corresponding to an ROI of 130.8% (2030), 626.1% (2040), and 1318.5% (2050). These are estimates, not guarantees.
Yes. The forecast implies it could exceed $100 by 2028, with 2027 average $98.42 and 2028 average $132.02, and a 2028 minimum of $105.54.
Bullish sentiment is indicated with a 30-day range of $65.75 to $85.94, RSI(14) at 30, SMA50 at $82.34, SMA200 at $73.88, support at $75.17, and resistance at $90.75.
Current price is $75.17 and the market cap is $2.6B, with a market-rank of 1847.
Diebold Nixdorf, Incorporated Community Discussion
0Share your Diebold Nixdorf, Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.